BIOLASE, Inc. (BIOLQ)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Feb 9, 2026
BIOLASE Market Cap
BIOLASE has a market cap or net worth of $7.32 thousand as of February 13, 2026. Its market cap has decreased by -99.70% in one year.
Market Cap
7.32K
Enterprise Value
15.60M
Revenue
46.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 12, 1992, BIOLASE's market cap has decreased from 43.61M to 7.32K, a decrease of -99.98%. That is a compound annual growth rate of -23.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 7.32K | 19,681.08% |
| Dec 30, 2025 | 37.00 | -99.99% |
| Dec 31, 2024 | 439.17K | -88.54% |
| Dec 29, 2023 | 3.83M | -23.61% |
| Dec 30, 2022 | 5.02M | -91.61% |
| Dec 31, 2021 | 59.78M | 53.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Advanced BioMedical Technologies | 14.18K |
| Capital Group Holdings | 11.31K |
| Medical Supply International USA | 10.23K |
| Wellstar International | 9.01K |
| Kelvin Medical | 6.73K |
| Acutus Medical | 5.98K |
| SurgLine International | 5.69K |
| Caliber Imaging & Diagnostics | 5.15K |